Goldman Sachs
PerkinElmer Reaches Deal for $1.5B Credit Facility
The agreement is for a new credit facility, which replaces one from 2019 that provided for a $1 billion unsecured revolving credit facility.
PerkinElmer Enters $500M Credit Facility
The proceeds will be used to pay, in part, PerkinElmer's $5.25B acquisition of BioLegend, announced last month.
Singular Genomics Ups IPO Target to $187M
The San Diego-based DNA sequencing startup plans to offer 8.5 million shares at an IPO price between $20 and $22 per share, for a $1.5 billion valuation.
Sequencing Startup Singular Genomics Files for $100M IPO
The San Diego-based company, led by a raft of Illumina veterans, is planning to build a new sequencing platform to address genomic and multiomic analysis.
Twist Bioscience Proposes $250M Public Offering
Included in the offering — Twist Bioscience's third this year — are 75,000 shares of common stock offered by certain selling shareholders.
Jul 29, 2020
Sema4 Raises $121M in Series C Financing Round
Aug 20, 2019
10x Genomics Files for $100M IPO
Dec 18, 2014
Goldman Sachs Downgrades Qiagen, Bruker
Jun 23, 2014
Goldman Sachs Reinstates Neutral Rating for Agilent
Mar 28, 2013